Skip to content

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.

Randomized controlled trial · Aliment Pharmacol Ther · 2009. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 19053980

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.

Silk DB, Davis A, Vulevic J et al.
Aliment Pharmacol Ther · 2009

PubMed ID
19053980
Record checked

Linked publication notices

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.